Aminex Therapeutics Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Puma Biotechnology.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 2000 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Los Angeles, US HQ |
Employees | Employees 82517% decrease | Employees 27214% decrease |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 136.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $228.4m (FY, 2025) |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods $58.2m (FY, 2025) |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit $170.2m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 172m |
For sources of this data, please see the company profile
View Company Profiles
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company